• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎会增加炎症性肠病的风险吗?对6100万参与者数据的荟萃分析。

Does Atopic Dermatitis Increase the Risk of Inflammatory Bowel Disease? A Meta-Analysis of Data from 61 Million Participants.

作者信息

Wan Mengjie, Yang Xiaoyang

机构信息

Department of Dermatology, Affiliated Haikou Hospital, Xiangya School Central South University and Haikou Municipal Municipal People's Hospital, Haikou, China.

Department of Hematology, Affiliated Haikou Hospital, Xiangya School Central South University and Haikou Municipal Municipal People's, Haikou, China.

出版信息

Int Arch Allergy Immunol. 2024 Nov 27:1-12. doi: 10.1159/000542777.

DOI:10.1159/000542777
PMID:39602916
Abstract

INTRODUCTION

This review aimed to examine if atopic dermatitis (AD) led to an increased risk of inflammatory bowel disease (IBD) by collating data from longitudinal studies.

METHODS

Cohort and case-control studies examining the risk of IBD, Crohn's disease (CD), or ulcerative colitis (UC) due to exposure to AD were included in this review. Articles were searched on PubMed, CENTRAL, Embase, Scopus, and Web of Science electronic repositories up to 2nd October 2024.

RESULTS

Eight retrospective cohort studies with 61,190,816 participants were included. The meta-analysis found that AD was a significant risk factor for IBD (OR: 1.37; 95% CI: 1.31, 1.43). No statistical heterogeneity was noted. Pooled analysis showed that exposure to AD was a significant risk factor for both CD (OR: 1.51; 95% CI: 1.31, 1.76) and UC (OR: 1.33; 95% CI: 1.13, 1.56). Both meta-analyses had high inter-study heterogeneity with I2 = 83% and I2 = 89%, respectively. Results remained significant on sensitivity analysis.

CONCLUSION

Our study shows an association between AD and IBD. The association was persistent for both CD and UC. Given the small increase in risk of IBD in AD, its clinical relevance may be questionable.

摘要

引言

本综述旨在通过整理纵向研究的数据,探讨特应性皮炎(AD)是否会增加炎症性肠病(IBD)的风险。

方法

本综述纳入了队列研究和病例对照研究,这些研究考察了因接触AD而导致IBD、克罗恩病(CD)或溃疡性结肠炎(UC)的风险。截至2024年10月2日,在PubMed、CENTRAL、Embase、Scopus和Web of Science电子数据库中检索相关文章。

结果

纳入了八项回顾性队列研究,共61190816名参与者。荟萃分析发现,AD是IBD的一个显著风险因素(OR:1.37;95%CI:1.31,1.43)。未发现统计学异质性。汇总分析表明,接触AD是CD(OR:1.51;95%CI:1.31,1.76)和UC(OR:1.33;95%CI:1.13,1.56)的显著风险因素。两项荟萃分析的研究间异质性都很高,I2分别为83%和89%。敏感性分析结果仍然显著。

结论

我们的研究表明AD与IBD之间存在关联。这种关联在CD和UC中均持续存在。鉴于AD中IBD的风险增加幅度较小,其临床相关性可能存疑。

相似文献

1
Does Atopic Dermatitis Increase the Risk of Inflammatory Bowel Disease? A Meta-Analysis of Data from 61 Million Participants.特应性皮炎会增加炎症性肠病的风险吗?对6100万参与者数据的荟萃分析。
Int Arch Allergy Immunol. 2024 Nov 27:1-12. doi: 10.1159/000542777.
2
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
3
Vitamin D for the treatment of inflammatory bowel disease.维生素 D 治疗炎症性肠病。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2.
4
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
5
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
6
Strategies for detecting colon cancer in patients with inflammatory bowel disease.炎症性肠病患者结肠癌的检测策略。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD000279. doi: 10.1002/14651858.CD000279.pub4.
7
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2004(2):CD000279. doi: 10.1002/14651858.CD000279.pub2.
8
An Updated Meta-analysis of Pancreatic Cancer Risk in Patients with Inflammatory Bowel Disease.炎症性肠病患者胰腺癌风险的最新荟萃分析
J Gastrointest Cancer. 2025 Jul 2;56(1):147. doi: 10.1007/s12029-025-01266-0.
9
Specific allergen immunotherapy for the treatment of atopic eczema.特异性变应原免疫疗法治疗特应性皮炎
Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD008774. doi: 10.1002/14651858.CD008774.pub2.
10
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.